Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...

Wall Street edged lower after getting pulled in opposite directions as President Donald Trump’s latest tariff escalation creates winners and losers among auto stocks. The S&P 500 slipped 0.3% Thursday ...

Pfizer (PFE) faces allegations from Senator Ron Wyden (D-Ore.) of running the largest tax-avoidance scheme in Big Pharma.

Wall Street is getting pulled in different directions as President Donald Trump’s latest tariff escalation creates winners ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: — Goldman ...

With its stock down 5.4% over the past month, it is easy to disregard Pfizer (NYSE:PFE). We, however decided to ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an Investor Day in New York City on Thursday, September 11, 2025, starting at 8:30 a.m. ET. Royalty Pharma senior executives will ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.